Contrast echocardiography: new agents.

In this report, we review the history, rationale, current status and future directions of contrast agents in echocardiography. First, we discuss the historic development of contrast agents through a review of important physical principles of microbubbles in ultrasonography. Second, we identify attributes of an ideal contrast agent and review those that are currently available or in the "pipeline" for clinical use. Third, we review indications for contrast echocardiography, including endocardial border detection, perfusion quantification and reperfusion assessment, and validate these observations by comparisons with other imaging modalities. Then, we briefly review different methodologies of performing a contrast study, including interrupted, real-time and a hybrid modality. Finally, we identify novel future applications of the newest contrast agents. These newer concepts in contrast echocardiography should form a foundation for nearly limitless application of echocardiography in improved anatomical assessment, perfusion imaging and even special applications, such as detection of vascular inflammation and site-specific drug delivery.

[1]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[2]  R. Gramiak,et al.  Echocardiographic detection of the pulmonary valve. , 1972, Radiology.

[3]  F J Ten Cate,et al.  Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. , 1984, Journal of the American College of Cardiology.

[4]  S. Kaul,et al.  Imaging of Myocardial Perfusion with SonoVue™ in Patients with a Prior Myocardial Infarction , 1999 .

[5]  R. Bing,et al.  Microbubble dynamics visualized in the intact capillary circulation. , 1984, Journal of the American College of Cardiology.

[6]  Ajit Raisinghani,et al.  Physical principles of microbubble ultrasound contrast agents. , 2002, The American journal of cardiology.

[7]  P. Grayburn,et al.  Assessment of myocardial perfusion by harmonic power Doppler imaging at rest and during adenosine stress: comparison with (99m)Tc-sestamibi SPECT imaging. , 2000, Circulation.

[8]  N de Jong,et al.  Usefulness of power Doppler contrast echocardiography to identify reperfusion after acute myocardial infarction. , 2001, The American journal of cardiology.

[9]  A. Jacobs,et al.  Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) , 1998, Circulation.

[10]  S. Kaul,et al.  Myocardial contrast echocardiography, single-photon emission computed tomography, and regional function analysis for coronary stenosis description during vasodilator stress. , 2003, The American journal of cardiology.

[11]  S. Kaul,et al.  Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. , 2000, Circulation.

[12]  M. McCulloch,et al.  Ultrasound contrast physics: A series on contrast echocardiography, article 3. , 2000, Journal of the American Society of Echocardiography.

[13]  P A van Der Wouw,et al.  Premature ventricular contractions during triggered imaging with ultrasound contrast. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  P. Pellikka,et al.  Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  R M Peshock,et al.  Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. , 1998, Journal of the American College of Cardiology.

[16]  R V Shohet,et al.  Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.

[17]  R. Erbel,et al.  Left ventricular volume determination using Albunex. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[19]  Harald Becher,et al.  Handbook of Contrast Echocardiography: Left ventricular function and myocardial perfusion , 2000 .

[20]  R Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[21]  A R Jayaweera,et al.  Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. , 1998, Circulation.

[22]  T C Skalak,et al.  Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and Its Local Effects on Tissue. , 1998, Circulation.

[23]  A R Jayaweera,et al.  Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? , 1997, Circulation.

[24]  N de Jong,et al.  Ultrasound contrast imaging: current and new potential methods. , 2000, Ultrasound in medicine & biology.

[25]  S. Kaul,et al.  Characterization of Spatial Patterns of Flow Within the Reperfused Myocardium by Myocardial Contrast Echocardiography Implications in Determining Extent of Myocardial Salvage , 1993, Circulation.

[26]  S. Kaul,et al.  Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. , 2002, Journal of the American College of Cardiology.

[27]  S. Kaul,et al.  Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. , 1997, Circulation.

[28]  Harald Becher,et al.  Handbook of Contrast Echocardiography , 2000, Springer Berlin Heidelberg.

[29]  O. Kamp,et al.  Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators. , 1998, Journal of the American College of Cardiology.

[30]  N. Nanda,et al.  Assessment of Myocardial Perfusion by Power Contrast Imaging Using a New Echo Contrast Agent , 2000, Echocardiography.

[31]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[32]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[33]  Julio E. Pérez,et al.  Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders. , 1995, American heart journal.

[34]  N. Nanda,et al.  Imagent Improves Endocardial Border Delineation, Inter‐reader Agreement, and the Accuracy of Segmental Wall Motion Assessment , 2003, Echocardiography.

[35]  Navin C. Nanda,et al.  Advances in Echo Imaging Using Contrast Enhancement , 1997, Springer Netherlands.

[36]  E. G. Tickner,et al.  Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. , 1980, Investigative radiology.

[37]  R. Gramiak,et al.  Echocardiography of the intra-atrial baffle in dextro-transposition of the great vessels. , 1975, Circulation.